{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:27:48Z","timestamp":1778527668790,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ygyno.2008.07.038","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T14:27:55Z","timestamp":1220538475000},"page":"289-297","source":"Crossref","is-referenced-by-count":52,"title":["Decreased survival in EGFR gene amplified vulvar carcinoma"],"prefix":"10.1016","volume":"111","author":[{"given":"Whitfield B.","family":"Growdon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Boisvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Akhavanfard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora C.","family":"Dias-Santagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Kojiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil S.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. John","family":"Iafrate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrell R.","family":"Borger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo R.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.07.038_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2008.07.038_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.AOG.0000202404.55215.72","article-title":"Carcinoma of the vulva","volume":"107","author":"Stehman","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2007.11.011","article-title":"Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States","volume":"108","author":"Stroup","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/1097-0142(20000701)89:1<116::AID-CNCR16>3.0.CO;2-4","article-title":"Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study","volume":"89","author":"Maggino","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.07.038_bib5","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.07.038_bib6","first-page":"218","article-title":"A review of EGFR targeted therapy","volume":"1","author":"Baselga","year":"2003","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(05)70142-X","article-title":"Who will benefit from treatment against EGFR?","volume":"6","author":"Arribas","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib8","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.2005.11.890","article-title":"Critical update and emerging trends in epidermal growth factor receptor targeting in cancer","volume":"23","author":"Baselga","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0014-4827(02)00104-0","article-title":"ErbB-targeted therapeutic approaches in human cancer","volume":"284","author":"Arteaga","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ygyno.2008.07.038_bib10","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.07.038_bib11","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1200\/JCO.2005.01.2823","article-title":"Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study","volume":"23","author":"Hirsch","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib12","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","article-title":"Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas","volume":"24","author":"Chung","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(05)70102-9","article-title":"Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study","volume":"6","author":"Moroni","year":"2005","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib14","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/sj.bjc.6601873","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors","volume":"90","author":"Ranson","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.07.038_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.lungcan.2006.08.015","article-title":"Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer","volume":"54","author":"Jeon","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ygyno.2008.07.038_bib16","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis","volume":"21","author":"Hirsch","year":"2003","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.ygyno.2008.07.038_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2008.02.008","article-title":"EGFR FISH versus mutation: different tests, different end-points","author":"Cappuzzo","year":"2008","journal-title":"Lung. Cancer"},{"key":"10.1016\/j.ygyno.2008.07.038_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/annonc\/mdm492","article-title":"EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients","volume":"19","author":"Cappuzzo","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ygyno.2007.05.006","article-title":"Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva","volume":"106","author":"Olawaiye","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib20","first-page":"381","article-title":"Expression of epidermal growth factor receptor and HER-2\/neu in normal and neoplastic cervix, vulva, and vagina","volume":"76","author":"Berchuck","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib21","first-page":"285","article-title":"Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas","volume":"46","author":"Gullick","year":"1986","journal-title":"Cancer. Res."},{"key":"10.1016\/j.ygyno.2008.07.038_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ygyno.2006.07.035","article-title":"EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction","volume":"104","author":"Oonk","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/gyno.1997.4660","article-title":"Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival","volume":"65","author":"Johnson","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib24","first-page":"918","article-title":"Analysis of invasive squamous cell carcinoma of the vulva and vulvar intraepithelial neoplasia for the presence of human papillomavirus DNA","volume":"77","author":"Rusk","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.AOG.0000187301.76283.7f","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"106","author":"Jones","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib26","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/89.20.1516","article-title":"Cofactors with human papillomavirus in a population-based study of vulvar cancer","volume":"89","author":"Madeleine","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2008.07.038_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/modpathol.3801010","article-title":"Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva","volume":"21","author":"Sutton","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.ygyno.2008.07.038_bib29","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ijc.22355","article-title":"Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer","volume":"120","author":"Reimers","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.07.038_bib30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejca.2006.09.025","article-title":"EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil","volume":"43","author":"Na","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.07.038_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ncponc0165","article-title":"Does epidermal growth factor receptor status predict activity of cetuximab in colorectal cancer patients?","volume":"2","author":"Baselga","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/pgp.0b013e3180555999","article-title":"Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB-1 immunoreactivity","volume":"26","author":"Brustmann","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib33","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1200\/JCO.2005.09.111","article-title":"Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients","volume":"23","author":"Cappuzzo","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib34","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/nar\/17.7.2503","article-title":"Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)","volume":"17","author":"Newton","year":"1989","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.ygyno.2008.07.038_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/11751","article-title":"Detection of PCR products using self-probing amplicons and fluorescence","volume":"17","author":"Whitcombe","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib36","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1093\/nar\/28.19.3752","article-title":"Mode of action and application of Scorpion primers to mutation detection","volume":"28","author":"Thelwell","year":"2000","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.ygyno.2008.07.038_bib37","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1200\/JCO.2006.06.7595","article-title":"Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines","volume":"24","author":"Lenz","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/JCM.34.3.745-747.1996","article-title":"Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas","volume":"34","author":"Baay","year":"1996","journal-title":"J. Clin. Microbiol."},{"issue":"Pt 4","key":"10.1016\/j.ygyno.2008.07.038_bib39","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","article-title":"The use of general primers GP5 and GP6 elongated at their 3\u2032 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR","volume":"76","author":"de Roda Husman","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1991.03460040048027","article-title":"Genital human papillomavirus infection in female university students as determined by a PCR-based method","volume":"265","author":"Bauer","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2008.07.038_bib41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.07.038_bib42","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/annonc\/mdm003","article-title":"Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib","volume":"18","author":"Hirsch","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-008-0053-5","article-title":"Targeting the epidermal growth factor receptor in high-grade astrocytomas","author":"Voelzke","year":"2008","journal-title":"Curr. Treat Options Oncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11060-005-0603-7","article-title":"HER1\/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme","volume":"74","author":"Raizer","year":"2005","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ygyno.2008.07.038_bib45","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa051918","article-title":"Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors","volume":"353","author":"Mellinghoff","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.07.038_bib46","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1073\/pnas.0510284103","article-title":"Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors","volume":"103","author":"Ji","year":"2006","journal-title":"Proc. Natl. Acad Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2008.07.038_bib47","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1158\/1078-0432.CCR-07-4171","article-title":"Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors","volume":"14","author":"Steffensen","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.07.038_bib48","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa072685","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod","volume":"358","author":"van Seters","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.07.038_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0029-7844(96)00376-6","article-title":"Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction","volume":"89","author":"Iwasawa","year":"1997","journal-title":"Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808005477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808005477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T03:27:08Z","timestamp":1588908428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808005477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0090825808005477"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.07.038","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}